• 1
    Meyers CA. Issues of quality of life in neuro-oncology. In: VechtCJ, editor. Handbook of clinical neurology. Neuro-oncology, Part I. Brain tumors: principles of biology, diagnosis and therapy. Volume 67. Amsterdam: Elsevier, 1997: 389409.
  • 2
    Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology. 2000; 14: 7579.
  • 3
    Silverberg E, Boring CC, Squires TS. Cancer statistics 1990. CA Cancer J Clin. 1990; 40: 926.
  • 4
    Wolff AC. Systemic therapy. Curr Opin Oncol. 1999; 11: 468474.
  • 5
    Green M, Hortobagyi GN. Neoadjuvant chemotherapy for operable breast cancer. Oncology (Huntingt). 2002; 16: 871884.
  • 6
    Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy. J Neurol. 1998; 245: 695708.
  • 7
    Lipp HP. Neurotoxicity (including sensory toxicity) induced by cytostatics. In: LippHP, editor. Anticancer drug toxicity prevention, management, and clinical pharmacokinetics. New York: Marcel Dekker, 1999: 431454.
  • 8
    Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2000; 18: 26952701.
  • 9
    Schagen SB, van Dam FS, Muller MJ, et al. Cognitive deficits after postoperative chemotherapy for breast carcinoma. Cancer. 1999; 85: 640650.
  • 10
    van Dam FS, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 1998; 90: 210218.
  • 11
    Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology. 1995; 4: 6166.
  • 12
    Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002; 20: 485493.
  • 13
    Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003; 21: 41754183.
  • 14
    Lezak MD. Neuropsychological assessment (3rd edition). New York: Oxford University Press, 1995.
  • 15
    Wechsler D. Wechsler Adult Intelligence Scale—revised. San Antonio: The Psychological Corporation, 1981.
  • 16
    Wechsler D. Wechsler Adult Intelligence Scale (3rd edition). San Antonio: The Psychological Corporation, 1997.
  • 17
    Wechsler D. Wechsler Memory Scale (3rd edition). San Antonio: The Psychological Corporation, 1997.
  • 18
    Reitan RM, Davison LA. Clinical neuropsychology: current status and applications. New York: Hemisphere Publishing Corp., 1974.
  • 19
    Reitan RM, Wolfson D. The Halstead–Reitan neuropsychological test battery. Tucson: Neuropsychology Press, 1985.
  • 20
    Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991; 5: 125142.
  • 21
    Hannay HJ, Levin, HS. Selective Reminding Test: an examination of the equivalence of four forms. J Clin Exp Neuropsychol. 1985; 7: 251263.
  • 22
    Fletcher JM. Memory for verbal and nonverbal stimuli in learning disabled subgroups: analysis by selective reminding. J Exp Child Psychol. 1985; 40: 244259.
  • 23
    Osterrieth PA. Le test de copie d'une figure complexe. Arch Psychologie. 1944; 30: 206356. [translated by Corwin J, Bylsma FW]. Clin Neuropsychol. 1993; 7: 915.
  • 24
    Benton AL, Hamsher K. Multilingual aphasia examination. Iowa City: AJA Associates, 1983.
  • 25
    Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test (2nd edition). Philadelphia: Lea & Febiger, 1983.
  • 26
    DeFilippis NA, McCampbell E, Rogers P. Development of a booklet form of the Category Test: normative and validity data. J Clin Neuropsychol. 1979; 1: 339342.
  • 27
    Benton AL, Hamsher KD, Varney NR, Spreen O. Contributions to neuropsychological assessment: a clinical manual. New York: Oxford University Press, 1983.
  • 28
    Klove H. Clinical neuropsychology. Med Clin North Am. 1963; 46: 16471658.
  • 29
    Beck AT, Steer RA. Beck Depression Inventory manual. San Antonio: The Psychological Corporation, 1987.
  • 30
    Beck AT, Steer RA, Brown GK. BDI-II manual. San Antonio: The Psychological Corporation, 1996.
  • 31
    Hathaway SR, McKinley JC. Minnesota multiphasic personality inventory. Minneapolis: National Computer Systems, 1970.
  • 32
    Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. The state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, 1983.
  • 33
    Beck AT, Steer RA. Beck Anxiety Inventory manual. San Antonio: The Psychological Corporation, 1993.
  • 34
    Greene RL. The MMPI-2/MMPI: an interpretive manual. Boston: Allyn and Bacon, 1991.
  • 35
    Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manage. 2001; 21: 407424.
  • 36
    Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003; 95: 190197.
  • 37
    Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer. 1995; 12: 231235.
  • 38
    Korol DL. Enhancing cognitive function across the life span. Ann N Y Acad Sci. 2002; 959: 167179.
  • 39
    Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the state of patients for the clinician. J Psychiatr Res. 1975; 12: 8998.
  • 40
    Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003; 21: 35573558.
  • 41
    Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001; 344: 395402.
  • 42
    Rasmussen L, Johnson T, Kuipers HM, et al. Does anaesthesia cause postoperative cognitive dysfunction? A randomized study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. 2003; 47: 260266.
  • 43
    Browndyke JN, Moser DJ, Cohen RA, et al. Acute neuropsychological functioning following cardiosurgical interventions associated with the production of intraoperative cerebral microemboli. Clin Neuropsychol. 2002; 16: 463471.
  • 44
    Zec RF, Trivedi MA. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev. 2002; 12: 65109.
  • 45
    Sherwin B. Estrogen and cognitive functioning in women. Proc Soc Exp Biol Med. 1998; 217: 1722.
  • 46
    Varney NR, Syrop C, Kubu CS, Struchen M, Hahn S, Franzen K. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet. 1993; 10: 5357.